Abstract
Kidney disease is a frequent complication after haematopoietic stem cell transplant (SCT), with glomerulopathies reported in up to 1–6% of allogeneic SCT recipients. Membranous nephropathy is the commonest reported, followed by minimal change nephropathy. Recent work has identified a target antigen in post-SCT membranous nephropathy. We describe seven cases of post-SCT nephrotic syndrome due to de novo glomerulopathy. In the changing landscape of post-SCT glomerulopathy, we review the literature and describe how our cases demonstrate that heterogeneity of presentation and response to treatment is underscored by important clinical and histopathological factors that should be considered in the workup and management of these conditions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
